Piperidine, 1-(3-chloropropyl)- → 7-(3-(Piperidin-1-yl)propoxy)naphthalene-2-sulfonic acid

HRID 528808노트

반응식

HRID 528808 반응식
[O-:1][C:2]1[CH:11]=[C:10]2[C:5]([CH:6]=[CH:7][C:8]([S:12]([O-:15])(=[O:14])=[O:13])=[CH:9]2)=[CH:4][CH:3]=1.[Na+].[Na+].Cl[CH2:19][CH2:20][CH2:21][N:22]1[CH2:27][CH2:26][CH2:25][CH2:24][CH2:23]1>>[N:22]1([CH2:21][CH2:20][CH2:19][O:1][C:2]2[CH:11]=[C:10]3[C:5]([CH:6]=[CH:7][C:8]([S:12]([OH:15])(=[O:13])=[O:14])=[CH:9]3)=[CH:4][CH:3]=2)[CH2:27][CH2:26][CH2:25][CH2:24][CH2:23]1

참가 물질

3

실험 절차

Following a procedure analogous to that for the synthesis of Intermediate 26B, sodium 7-oxidonaphthalene-2-sulfonate (Pfaltz and Bauer, 200 mg, 0.75 mmol) and 1-(3-chloropropyl)piperidine (121 mg, 0.75 mmol) were converted to the title compound (78 mg, 30%). MS(ESI+) m/z 336.1 (M+H)+.

출처 및 근거

ORD 기록
ord-ea260d7f1f624948bb476786c2fe0972
출처 데이터셋
uspto-grants-2016_05
특허 번호
US09346795B2

반응 노트

불러오는 중…